Accession Number: | 0001209191-21-061561 |
Date: | 2021-10-22 |
Issuer: | ALBIREO PHARMA, INC. (ALBO) |
Original Submission Date: |
HORN PATRICK TAYLOR
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 1000
BOSTON, MA 02109
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-10-22 | S | 95 | d | $28.83 | 12,355 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | shares sold pursuant to a rule 10b5-1 arrangement established in october 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $28.80 to $28.9187, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. |
f3 | represents 5,292 shares of common stock and 7,063 restricted stock units. |